Tag archive for ‘D. Keith Grossman’
By pharmanewsdaily On Friday, May 22nd, 2020

Nevro’s Senza Omnia SCS system gets CE mark for chronic pain treatment

US medical device company Nevro has secured CE mark approval for its Senza Omnia spinal cord stimulation system (Senza Omnia SCS system) for delivering its HF10 therapy for the treatment of chronic pain. The Omnia More...